ProfileGDS4718 / 224506_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 49% 52% 75% 54% 55% 50% 46% 56% 55% 55% 49% 53% 53% 52% 47% 54% 50% 53% 47% 52% 52% 54% 55% 56% 55% 50% 50% 45% 52% 47% 53% 54% 60% 48% 52% 51% 49% 58% 58% 77% 53% 43% 58% 44% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.438149
GSM549102patient 115, normal, homogenized [OPG study]5.6598652
GSM549104patient 119, normal, homogenized [OPG study]7.3813375
GSM549108patient 138, normal, homogenized [OPG study]5.7767354
GSM549119patient 077, normal, homogenized [OPG study]5.7924855
GSM549133patient 032, cancer, homogenized [OPG study]5.4640950
GSM549139patient 042, cancer, homogenized [OPG study]5.2660246
GSM549099patient 107, normal, homogenized [OPG study]5.8451956
GSM549109patient 139, normal, homogenized [OPG study]5.8307455
GSM549110patient 046, normal, homogenized [OPG study]5.8049555
GSM549114patient 063, normal, homogenized [OPG study]5.4116349
GSM549122patient 082, normal, homogenized [OPG study]5.7142353
GSM549134patient 033, cancer, homogenized [OPG study]5.645653
GSM549136patient 036, cancer, homogenized [OPG study]5.5749552
GSM549140patient 044, cancer, homogenized [OPG study]5.3050447
GSM549111patient 047, normal, homogenized [OPG study]5.749754
GSM549113patient 057, normal, homogenized [OPG study]5.4598350
GSM549132patient 031, cancer, homogenized [OPG study]5.6898253
GSM549137patient 038, cancer, homogenized [OPG study]5.3351347
GSM549142patient 047, cancer, homogenized [OPG study]5.7546452
GSM549100patient 110, normal, homogenized [OPG study]5.6575452
GSM549107patient 135, normal, homogenized [OPG study]5.7128254
GSM549115patient 068, normal, homogenized [OPG study]5.7864155
GSM549116patient 072, normal, homogenized [OPG study]5.8683456
GSM549120patient 078, normal, homogenized [OPG study]5.8350455
GSM549131patient 030, cancer, homogenized [OPG study]5.4333950
GSM549118patient 074, normal, homogenized [OPG study]5.5357550
GSM549129patient 027, cancer, homogenized [OPG study]5.2669345
GSM549123patient 088, normal, homogenized [OPG study]5.62252
GSM549124patient 006, cancer, homogenized [OPG study]5.362547
GSM549126patient 015, cancer, homogenized [OPG study]5.6753
GSM549128patient 025, cancer, homogenized [OPG study]5.7550754
GSM549103patient 117, normal, homogenized [OPG study]6.1397960
GSM549117patient 073, normal, homogenized [OPG study]5.3546448
GSM549138patient 041, cancer, homogenized [OPG study]5.6292352
GSM549141patient 045, cancer, homogenized [OPG study]5.543451
GSM549130patient 028, cancer, homogenized [OPG study]5.462349
GSM549101patient 111, normal, homogenized [OPG study]6.0110358
GSM549105patient 128, normal, homogenized [OPG study]6.0336558
GSM549106patient 134, normal, homogenized [OPG study]7.7023777
GSM549112patient 048, normal, homogenized [OPG study]5.6588453
GSM549125patient 011, cancer, homogenized [OPG study]5.1652243
GSM549127patient 024, cancer, homogenized [OPG study]6.0399158
GSM549135patient 035, cancer, homogenized [OPG study]5.1659244